Bullying-related victimization is a multifaceted psychosocial stressor associated with a spectrum of adverse mental health outcomes, including depression, anxiety disorders, post-traumatic stress symptoms, suicidality, and maladaptive emotion regulation. Although the quoted text frames social conflict as reciprocal (“you were a bully… now you play victim”), clinical psychiatry focuses on the individual harm that occurs when a person experiences repeated aggression, humiliation, exclusion, or coercive control. In mental health research, bullying is generally conceptualized as intentional harm or power imbalance occurring over time, and it can be delivered through direct verbal or physical acts, relational aggression, or cyber contexts.
Neurobiologically and psychologically, chronic bullying functions as a sustained threat. Repeated exposure activates stress-response systems, including hypothalamic–pituitary–adrenal (HPA) axis signaling and sympathetic arousal, which can dysregulate cortisol rhythms and heighten vigilance. Over time, this physiological state can contribute to sleep disturbance, concentration impairment, and somatic symptoms (e.g., headaches, gastrointestinal complaints), which then further worsen mood and anxiety. Cognitive models explain that victimization fosters maladaptive appraisals such as perceived lack of control, social inferiority, and negative expectations about safety and relationships. These beliefs can precipitate ruminative thinking, self-blame, and attentional bias toward threat cues, thereby maintaining anxiety and depressive symptoms.
The clinical presentation of bullying-related distress varies by developmental stage and personality vulnerability. Common symptoms include persistent sadness, irritability, social withdrawal, loss of interest, and guilt, alongside anxiety symptoms such as excessive worry, panic-like episodes, and avoidance of social settings. Trauma-related frameworks are also relevant: repeated humiliation and coercion can produce intrusion symptoms, heightened startle response, and negative alterations in mood and cognition, meeting criteria for trauma- and stressor-related disorders in some cases. Importantly, victims may also develop anger and retaliatory impulses, which can reflect either overlapping internalizing and externalizing pathways or attempts to regain perceived agency.
Risk factors for worse outcomes include severity and duration of bullying, lack of social support, pre-existing mental health conditions, limited coping resources, family conflict, and neurodevelopmental vulnerabilities such as attention or emotion regulation difficulties. Systemic factors—school or workplace tolerance of harassment, inconsistent consequences, and online disinhibition—can increase chronicity. Cultural and individual differences in help-seeking, stigma, and perceived legitimacy of reporting also influence severity and treatment delay. Conversely, protective factors include supportive relationships (family, peers, mentors), effective bystander intervention, and environments that promptly address harassment.
Evidence-based interventions target both symptom reduction and the social conditions that sustain harm. Psychotherapeutic approaches often include cognitive behavioral therapy (CBT) to modify catastrophic interpretations, reduce rumination, and improve behavioral activation. Trauma-focused CBT or trauma-informed care may be appropriate when intrusion and hyperarousal predominate. For adolescents and young adults, interventions that build coping skills, emotion regulation (e.g., distress tolerance), and assertiveness can reduce avoidance and restore social engagement. Parent- or caregiver-involved components are frequently helpful when victims are minors, because caregiver validation and coordinated safety planning improve adherence and outcomes.
On the pharmacologic side, there is no medication that “treats bullying” directly, but clinicians may treat comorbid disorders—such as major depressive disorder or generalized anxiety disorder—with standard treatments (for example, SSRIs/SNRIs) when symptoms meet diagnostic criteria and cause impairment. Pharmacotherapy should be paired with psychosocial interventions, especially when ongoing harassment continues. Safety planning is essential, particularly when there is suicidal ideation or self-harm risk.
For schools and organizations, prevention and mitigation are core public health strategies. Best practices include clear anti-bullying policies, consistent enforcement, staff training, reliable reporting mechanisms, and bystander programs that reduce passive acceptance. In cyber contexts, digital safety education, account management, moderation tools, and coordinated platform reporting can decrease exposure. Clinically, a thorough assessment should document the frequency, form (physical, verbal, relational, cyber), and impact of bullying, as well as the victim’s safety, support network, and current mental health symptoms.
Finally, the reciprocal framing in interpersonal conflicts can obscure the clinical priority: assessing harm and ensuring safety for the person experiencing distress. Victimization and perpetration can co-occur in some individuals, but effective care still requires trauma-informed evaluation, accountability processes that do not further traumatize, and targeted treatment for distress.
Source: [@kookoooks, X post]
Kon | waiting for Geonhwa ♦️& Seolhee 🗡️: @pencilfever You were a bully, honey. So now you play victim for receiving the same energy?. #breaking
— @kookoooks May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
